HLHyoeun Lee

Hyoeun Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hyoeun Lee has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Eun Na Kim

    Department of Clinical Pharmacology and Therapeutics, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

    2 shared publications
  • Kyun-Seop Bae

    Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    2 shared publications
  • Shi Hyang Lee

    Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    2 shared publications
  • Soo-Min Jung

    Department of Clinical Pharmacology and Therapeutics, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

    2 shared publications
  • Geonhyeok Kim

    Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea

    1 shared publication
  • Hong Ji Song

    Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea

    1 shared publication

Latest Publications

  • Open Access

    Effect of Food on the Pharmacokinetics, Pharmacodynamics, and Safety of Zastaprazan, a Potassium‐Competitive Acid Blocker, in Healthy Participants

    by Hyoeun Lee, Seok‐Kyu Yoon, Soo‐Min Jung, Moon Hee Lee, Shi‐Hyang Lee, Eun Na Kim, John Kim, Hyunju Cha, Kyun‐Seop Bae, Hyeong‐Seok Lim

    Zastaprazan (JP‐1366) is a novel potassium‐competitive acid blocker characterized by rapid onset and sustained acid suppression. This study aimed to evaluate the effect of food on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of zastaprazan in healthy participants. In this randomized, open‐label, two‐period crossover phase 1 study, 24 healthy participants received a single oral dose of zastaprazan 20 mg under fasted and fed conditions. PK parameters were evaluated using noncompartmental analysis, and PD effects were assessed through continuous intragastric pH monitoring. Under fed conditions, peak exposure (Cmax) decreased (geometric mean ratio [GMR], 0.6997; 90% confidence interval [CI], 0.6292–0.7781), whereas systemic exposure (AUC last ) increased (GMR, 1.3783; 90% CI, 1.2688–1.4973), accompanied by a delayed T max . Despite these PK differences, PD outcomes were comparable between fed and fasted conditions. The percentage of time with intragastric pH ≥ 4 over 24 h was similar under fed and fasted conditions (70.01% vs. 69.19%), with no meaningful differences observed in other pH‐based parameters. Zastaprazan was well tolerated, and no clinically significant safety concerns were identified. Food altered the rate and extent of zastaprazan absorption but did not affect its PD response. These findings indicate that food‐related PK changes do not meaningfully affect PD outcomes and support the administration of zastaprazan without regard to meals. This flexibility may enhance its clinical utility as an acid‐suppressive therapy. Trial Registration: The study was registered at ClinicalTrials.gov (NCT05712681)

  • Open Access

    Serum IGF-1 and IGFBP-3 levels in healthy Korean men aged 19–40 years: a cross-sectional analysis of reference ranges and seasonal variation

    by Soo-Min Jung, Shi-Hyang Lee, Hyoeun Lee, Eun Na Kim, Kyun-Seop Bae

    Serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) levels are regulated by growth hormone, nutritional status, and other endocrine factors, and are implicated in aging, metabolic disorders, and malignancies. Establishing appropriate reference ranges for these biomarkers is essential for safety monitoring and pharmacodynamic assessments in clinical trials. Although various detection methods—including enzyme-linked immunosorbent assay, chemiluminescence immunoassay, radioimmunoassay, and immunoradiometric assay (IRMA)—are available, defining reliable reference intervals remains challenging due to variability linked to age, sex, season, and assay methodology. IRMA manufacturers typically provide generalized reference values and recommend that laboratories establish context-specific ranges; however, data from healthy adult populations are limited. We analyzed data from 255 self-reported healthy Korean men aged 19–40 years using the IRMA method and R software. Age-specific reference ranges and standardized centile curves for serum IGF-1 and IGFBP-3 were established. Both biomarkers demonstrated significant seasonal variation, with notable differences observed among spring, autumn, and winter groups. This study presents a method for establishing institution-specific reference ranges and highlights the importance of considering seasonal variations to help reduce unnecessary dropouts during clinical trials.


  • Open Access

    Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect model

    by Hyoeun Lee, Seonghae Yoon, Jae Yong Chung

    Lee H, et al. Transl Clin Pharmacol. 2024 Sep;32(3):150-158. https://doi.org/10.12793/tcp.2024.32.e14


  • Open Access

    Clinical Characteristics Associated with Electrocardiographic Left Ventricular Hypertrophy in Clinical Normotensives without a History of Hypertension: a Cross-Sectional Study

    by Hyoeun Lee, Hong Ji Song, Yu-Jin Paek, Kyung-Hee Park, Hye-Mi Noh, Geonhyeok Kim, Young-Gyun Seo

    Background: This study evaluated factors independently associated with electrocardiographic left ventricular hypertrophy (ECG-LVH) in subjects who were normotensive on clinical measurement and had no prior history of hypertension. Methods: This cross-sectional study analyzed cases and controls in the Comprehensive Medical Examination Center of Hallym University Sacred Heart Hospital. Eligible case participants presented ECG-LVH according to the Sokolow-Lyon or Cornell criteria, were normotensive on clinical measurement, and had never received a diagnosis of hypertension. The control group comprised subjects with normal sinus rhythm who were normotensive on clinical measurement with no history of hypertension. Results: A multiple logistic regression model showed male sex, age and systolic blood pressure to be positively related to the presence of ECG-LVH. A positive relation of smoking and regular exercise; an inverse relation of pulse rate to the presence of ECG-LVH were found only in men. An inverse relation of uric acid level was found only in women. Detailed analyses of relatively healthy and young men according to whether or not to exercise regularly showed that positive relations of age and systolic blood pressure; an inverse relation of obesity to the presence of ECG-LVH were apparent in the non-regular exercise group but not in the regular exercise group. In the regular exercise group, only pulse rate showed significant (inverse) association with the presence of ECG-LVH. Conclusion: The varying risk factor profiles associated with ECG-LVH according to sex and the participation in regular exercise may help to elucidate the ECG-LVH in clinical normotensives with no prior history of hypertension.